BR9609026A - Composição processo para o tratamento do cáncer e de detecção para a produção de citicina por tumores para determinar a eficácia de um autólogo e kit diagnóstico para detecção para eficácia de compostos celulares autólogos - Google Patents
Composição processo para o tratamento do cáncer e de detecção para a produção de citicina por tumores para determinar a eficácia de um autólogo e kit diagnóstico para detecção para eficácia de compostos celulares autólogosInfo
- Publication number
- BR9609026A BR9609026A BR9609026A BR9609026A BR9609026A BR 9609026 A BR9609026 A BR 9609026A BR 9609026 A BR9609026 A BR 9609026A BR 9609026 A BR9609026 A BR 9609026A BR 9609026 A BR9609026 A BR 9609026A
- Authority
- BR
- Brazil
- Prior art keywords
- efficacy
- detection
- autologous
- cancer
- tumors
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 6
- 201000011510 cancer Diseases 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 102000004127 Cytokines Human genes 0.000 title abstract 2
- 108090000695 Cytokines Proteins 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 238000001514 detection method Methods 0.000 title 2
- 238000009007 Diagnostic Kit Methods 0.000 title 1
- 230000001413 cellular effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000000284 extract Substances 0.000 abstract 2
- 210000004881 tumor cell Anatomy 0.000 abstract 2
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 210000000170 cell membrane Anatomy 0.000 abstract 1
- 229960004397 cyclophosphamide Drugs 0.000 abstract 1
- 230000016396 cytokine production Effects 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001102—Receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/18—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6012—Haptens, e.g. di- or trinitrophenyl (DNP, TNP)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Developmental Biology & Embryology (AREA)
- Dentistry (AREA)
- Virology (AREA)
- Hospice & Palliative Care (AREA)
- Food Science & Technology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47901695A | 1995-06-07 | 1995-06-07 | |
| PCT/US1996/009511 WO1996040173A1 (en) | 1995-06-07 | 1996-06-06 | Hapten modified tumor cell extract and methods of treating or screening for cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9609026A true BR9609026A (pt) | 1999-07-06 |
Family
ID=23902311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9609026A BR9609026A (pt) | 1995-06-07 | 1996-06-06 | Composição processo para o tratamento do cáncer e de detecção para a produção de citicina por tumores para determinar a eficácia de um autólogo e kit diagnóstico para detecção para eficácia de compostos celulares autólogos |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0837687B1 (pt) |
| JP (1) | JPH11507633A (pt) |
| KR (1) | KR19990022592A (pt) |
| AT (1) | ATE386535T1 (pt) |
| AU (1) | AU727316B2 (pt) |
| BR (1) | BR9609026A (pt) |
| CA (1) | CA2222135A1 (pt) |
| DE (1) | DE69637440T2 (pt) |
| ES (1) | ES2302337T3 (pt) |
| IL (1) | IL122455A0 (pt) |
| WO (1) | WO1996040173A1 (pt) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998014206A1 (en) * | 1996-10-04 | 1998-04-09 | Thomas Jefferson University | T cells mediating an immune response and methods of use |
| WO2000009140A1 (en) * | 1997-07-24 | 2000-02-24 | Thomas Jefferson University | Composition and method of using tumor cells |
| IL137791A0 (en) * | 1998-02-17 | 2001-10-31 | Univ Jefferson | Hapten-modified tumor cell membranes and their use |
| EP1067960A2 (en) * | 1998-04-09 | 2001-01-17 | Thomas Jefferson University | A method of inducing an anti-tumor response against a lung metastasis in a melanoma patient |
| DE69939111D1 (de) * | 1998-05-04 | 2008-08-28 | Univ Jefferson | Verwendung von mit Hapten behandelten Tumorzellen und -extrakte |
| US6248585B1 (en) * | 1998-11-19 | 2001-06-19 | Thomas Jefferson University | Compositions for preserving haptenized tumor cells for use in vaccines |
| WO2000031542A1 (en) * | 1998-11-24 | 2000-06-02 | Thomas Jefferson University | Detection of t cell stimulating tumor antigens |
| WO2000038710A2 (en) * | 1998-12-30 | 2000-07-06 | Thomas Jefferson University | Dual hapten modified tumor cells and tumor polypeptides and methods of treating cancer |
| DE60031100T2 (de) * | 1999-03-16 | 2007-03-08 | Thomas Jefferson University | Hapten modifizierte tumorzellen und verfahren zur herstellung und deren verwendung |
| US7297330B2 (en) | 2000-02-04 | 2007-11-20 | Thomas Jefferson University | Low dose haptenized tumor cell and tumor cell extract immunotherapy |
| US20040076646A1 (en) * | 2001-07-18 | 2004-04-22 | Caplan Michael J. | Haptenizing cancer cell components |
| CA2489076A1 (en) | 2002-06-10 | 2003-12-18 | Avax Technologies Inc. | Cryopreservation of haptenized tumor cells |
| AU2005271893A1 (en) * | 2004-07-10 | 2006-02-16 | Alexion Pharmaceuticals, Inc. | Antibodies against cancer produced using masked cancer cells as immunogen |
| US20090004213A1 (en) | 2007-03-26 | 2009-01-01 | Immatics Biotechnologies Gmbh | Combination therapy using active immunotherapy |
| JP2022502493A (ja) * | 2018-09-24 | 2022-01-11 | バイオヴァクシーズ インコーポレイテッド | 二ハプテン化自己ワクチン及びその使用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0268640A4 (en) * | 1986-05-07 | 1989-11-30 | Sloan Kettering Inst Cancer | VACCINE STIMULATING OR IMPROVING THE PRODUCTION OF ANTIBODIES AGAINST GM2. |
| US5662896A (en) * | 1988-03-21 | 1997-09-02 | Chiron Viagene, Inc. | Compositions and methods for cancer immunotherapy |
| GB2218420B (en) * | 1988-04-12 | 1992-07-15 | British Bio Technology | Synthetic gene encoding interleukin 4 |
| JP2984366B2 (ja) * | 1989-04-05 | 1999-11-29 | バイオミラ、インコーポレーテッド | 免疫抑制ムチンを生成する腺がんの能動的特異免疫療法 |
| US5290551A (en) * | 1990-05-08 | 1994-03-01 | Thomas Jefferson University | Treatment of melanoma with a vaccine comprising irradiated autologous melanoma tumor cells conjugated to a hapten |
| WO1995015334A1 (en) * | 1993-11-30 | 1995-06-08 | California Pacific Medical Center Research Institute | cDNA PROBE FOR BREAST CANCER DIAGNOSIS AND TREATMENT |
| US7297330B2 (en) * | 2000-02-04 | 2007-11-20 | Thomas Jefferson University | Low dose haptenized tumor cell and tumor cell extract immunotherapy |
-
1996
- 1996-06-06 AU AU62620/96A patent/AU727316B2/en not_active Ceased
- 1996-06-06 DE DE69637440T patent/DE69637440T2/de not_active Expired - Lifetime
- 1996-06-06 EP EP96921381A patent/EP0837687B1/en not_active Expired - Lifetime
- 1996-06-06 CA CA002222135A patent/CA2222135A1/en not_active Abandoned
- 1996-06-06 JP JP9501816A patent/JPH11507633A/ja not_active Withdrawn
- 1996-06-06 AT AT96921381T patent/ATE386535T1/de not_active IP Right Cessation
- 1996-06-06 BR BR9609026A patent/BR9609026A/pt unknown
- 1996-06-06 KR KR1019970709073A patent/KR19990022592A/ko not_active Application Discontinuation
- 1996-06-06 WO PCT/US1996/009511 patent/WO1996040173A1/en active IP Right Grant
- 1996-06-06 IL IL12245596A patent/IL122455A0/xx unknown
- 1996-06-06 ES ES96921381T patent/ES2302337T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPH11507633A (ja) | 1999-07-06 |
| CA2222135A1 (en) | 1996-12-19 |
| EP0837687A1 (en) | 1998-04-29 |
| MX9709733A (es) | 1998-10-31 |
| AU6262096A (en) | 1996-12-30 |
| ATE386535T1 (de) | 2008-03-15 |
| KR19990022592A (ko) | 1999-03-25 |
| IL122455A0 (en) | 1998-06-15 |
| WO1996040173A1 (en) | 1996-12-19 |
| ES2302337T3 (es) | 2008-07-01 |
| EP0837687A4 (en) | 2001-06-27 |
| AU727316B2 (en) | 2000-12-07 |
| DE69637440D1 (de) | 2008-04-03 |
| DE69637440T2 (de) | 2009-03-05 |
| EP0837687B1 (en) | 2008-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9609026A (pt) | Composição processo para o tratamento do cáncer e de detecção para a produção de citicina por tumores para determinar a eficácia de um autólogo e kit diagnóstico para detecção para eficácia de compostos celulares autólogos | |
| Fournier et al. | Application of phorbol ester to mouse skin causes a rapid and sustained loss of protein kinase C | |
| WO1998035985B1 (en) | Protein markers for lung cancer and use thereof | |
| ATE353974T1 (de) | Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs | |
| DE50011820D1 (de) | Verfahren zur kultivierung von krebszellen aus humangewebe und vorrichtung zur aufbereitung von gewebeproben | |
| MXPA02006145A (es) | Metodo para el aislamiento de arn de especimenes de tejido incluido en parafina fijo en formalina. | |
| DE69735851D1 (de) | Verfahren zur aktivierung von menschlichen, antigen-aktivierenden zellen, aktivierte menschliche, antigen-aktivierende zellen und anwendungen derselben | |
| GR1000477B (el) | Νεο μονοκλωνικο αντισωμα κατα νεου αντιγονου που σχετιζεται με ανθρωπινους ογκους. | |
| AU2738195A (en) | Tumor diagnosis and prognosis | |
| DE60020529D1 (de) | Antikörper zur krebsbehandlung und -diagnose | |
| AR032743A1 (es) | Composiciones y metodos para la terapia y el diagnostico de cancer de pulmon | |
| RU95108385A (ru) | Пептиды, способ их получения, фармацевтическая композиция и способ ее получения | |
| HUP9800028A2 (hu) | Több tumor esetében rendellenes sejtszaporodás előidézésében közrejátszó gének | |
| DE60126495D1 (de) | Nukleinsäure und protein, genannt 158p1d7, für die behandlung und erkennung von blasenkrebs und anderen krebsarten | |
| ATE428928T1 (de) | Verfahren zur einführung von heterologischen zellen in fische | |
| DE69940770D1 (de) | Vervielfältigung und nachweis von ebv barf1 zur diagnose von nasopharyngealen karzinom | |
| NO932101D0 (no) | Polypeptidmateriale som er anvendelig ved terapeutisk behandling av mennesker | |
| ES8206855A1 (es) | Un procedimiento para la preparacion de anticuerpos con especialidad frente a antigenos encontrados en los nucleos y nu-cleolos de las celulas humanas cancerosas. | |
| DE69803279D1 (de) | Schnelle krebs-diagnose | |
| ATE512216T1 (de) | Nukleinsäure und dieser entsprechendes, 184p1e2 genanntes, für die behandlung und den nachweis von krebs geeignetes protein | |
| Giri et al. | Protein and RNA synthesis during spore germination in the cellular slime mold Dictyostelium discoideum | |
| ATE403716T1 (de) | Nukleinsäure und korrespondierendes protein 85p1b3, nützlich zur behandlung und detektion von krebserkrankungen | |
| Gutin et al. | S1 nuclease from Aspergillus oryzae for the detection of DNA damage and repair in the gamma-irradiated intracerebral rat gliosarcoma 9L | |
| DE19724546C2 (de) | Pharmazeutische Zusammensetzung zur Behandlung von Krebs sowie Kit zur Herstellung dieser Zusammensetzung | |
| Busch et al. | Studies on the human tumor nucleolar antigens |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |